Globus Medical Inc (GMED)
Globus Medical makes surgical implants and devices, including spinal products, used by surgeons. It last closed at $70.02 on Nov 17, down 0.77% on the day. GMED last reported earnings on Thu, Nov 5, 2026. The average 12-month price target from 6 analysts is $93.00 (+32.8% from the last close), with a high of $105.00 and a low of $78.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). In the past 30 days there were 5 dark pool prints totaling $4.5M, the largest $1.6M.
Key Stats
Last 12 monthsNot reported for this period.
From GMED's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 6 analysts who set a price target on GMED in the past 90 days. The average target is $93.00, with a high of $105.00 and a low of $78.00, compared with the last close of $70.02.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 9 | Truist Securities | Target lowered | Buy | $100 → $90 |
| Nov 6 | Canaccord Genuity | Maintained | Buy | $105 |
| Nov 6 | Wells Fargo | Target raised | Buy | $99 → $100 |
| Nov 6 | Needham | Maintained | Buy | $100 |
| Nov 6 | BMO Capital | Downgrade | Hold | $78 |
Technical Analysis
The stock is 11% below its 20 day and 9% below its 50 day average. It is 18% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39), near oversold. The nearest support is the 52 week low at $69.49, and the nearest resistance the Pivot at $70.15.
| RSI (14) | 38.96 | Weak, oversold below 30 | Neutral |
| MACD | -1.72 | Below its signal line | Bearish |
| Stochastic | 4.9 | Near the bottom of its range | Oversold |
| ADX (14) | 23.0 | Weak trend | |
| Williams %R | -97.2 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -134.2 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −12.0% | Change over 10 sessions | Bearish |
| ATR (14) | $3.15 | Typical daily range, 4.5% of price |
| RSI (14) | 39.41 | Weak, oversold below 30 | Neutral |
| MACD | -2.52 | Below its signal line | Bearish |
| Stochastic | 4.9 | Near the bottom of its range | Oversold |
| ADX (14) | 12.6 | No clear trend | |
| Williams %R | -97.3 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -154.3 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −5.6% | Change over 10 sessions | Bearish |
| ATR (14) | $6.18 | Typical daily range, 8.8% of price |
What happened before
See how GMED did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How GMED has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.
Whale Options Flow
90DNo whale options trades in GMED in the last 90 days.
Dark Pool
30DGMED Institutional Ownership
Full report →- ▲317 buying vs 262 selling
- ●Held by funds -0.4 pts
- ▲Funds holding +12
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 614 | 602 | +2.0% |
| In funds' top 10 | 11 | 11 | 0.0% |
| Held by funds | 89.0% | 89.3% | −0.4 pts |
| New / increased | 87 / 230 | 75 / 251 | −2.8% |
| Reduced / sold out | 192 / 70 | 178 / 88 | −1.5% |
| Put/call ratio | 2.16 | 0.11 | +1910.4% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GMED is in one of them and how their past GMED trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GMED in an article yet. Here's the latest on the wider market.
GMED Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Sep 3, 2026 | Oct 12, 2026 | 39 d |
| Gilbert CisnerosD · CA | Buy | $15K – $50K | Aug 19, 2026 | Sep 11, 2026 | 23 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Mar 3, 2026 | Apr 7, 2026 | 35 d |
| Lisa McClainR · MI | Sell | $1K – $15K | Jul 10, 2025 | Aug 13, 2025 | 34 d |
| Lisa McClainR · MI | Sell (partial) | $1K – $15K | Jun 24, 2025 | Aug 13, 2025 | 50 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Globus Medical
Globus Medical is a medical device company based in Audubon, Pennsylvania. It makes surgical implants and devices, including spinal products such as cervical artificial discs, spinal cord stimulation systems, and a scoliosis correction system, along with human tissue products used in surgery. Its products are used by surgeons in the United States and in other countries, and each must meet the rules of the regulators where it is sold.
- Headquarters
- Audubon, PA
- Founded
- 2003
- Website
- globusmedical.com ↗









